A new platinum-complex showing easy preparation, promising anti-tumor activity, and better efficacy and distribution properties than oxaliplatin
Abstract
Current clinically used chemotherapeutic platinum
* Corresponding authors
a
College of Pharmaceutical Sciences, Capital Medical University, Beijing 100069
E-mail:
mingzhao@mail.bjmu.edu.cn, sqpeng@mail.bjmu.edu.cn
Fax: +86-10-8391-1533
Tel: +86-10-8391-1535
Current clinically used chemotherapeutic platinum
Y. Wang, G. Kang, M. Zhao, J. Wu, X. Zhang, Y. Yang, J. Liu and S. Peng, Mol. BioSyst., 2011, 7, 3245 DOI: 10.1039/C1MB05266G
To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.
If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.
If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.
Read more about how to correctly acknowledge RSC content.
Fetching data from CrossRef.
This may take some time to load.
Loading related content